Hot Features
Premium
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Period:
Draw Mode:
| Volume | 83,089 |
|
|||||
| News | - | ||||||
| Day High | Low High |
||||||
| Day Low | |||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Psyence Biomedical Ltd | PBM | NASDAQ | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| -0.03 | -2.50% | 1.17 | 07:48:20 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 1.20 |
| Trades | Shares Traded | Average Volume | 52 Week Range |
|---|---|---|---|
| 394 | 83,089 | - | 0.5135 - 4.285 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 07:48:20 | 33 | US$ 1.17 | USD |
Psyence Biomedical Ltd Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| US$ 15.67M | - | - | - | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Psyence Biomedical News
| Date | Time | Source | News Article |
|---|---|---|---|
| 3/26/2024 | 10:06 | GlobeNewswire Inc. | Psyence Group Announces the Closing of the Previously.. |
| 3/11/2024 | 06:00 | GlobeNewswire Inc. | Psyence Group Provides Corporate Update Following Successful.. |
| 1/25/2024 | 16:17 | GlobeNewswire Inc. | Psyence Biomedical Ltd. Approved to List on Nasdaq following.. |
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical PBM Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.82 | 1.41 | 0.8058 | 1.18 | 1,277,539 | 0.35 | 42.68% |
| 1 Month | 1.08 | 1.41 | 0.6311 | 1.12 | 394,040 | 0.09 | 8.33% |
| 3 Months | 0.99 | 4.285 | 0.5135 | 1.84 | 3,888,659 | 0.18 | 18.18% |
| 6 Months | 2.21 | 4.285 | 0.5135 | 1.83 | 3,475,601 | -1.04 | -47.06% |
| 1 Year | 2.21 | 4.285 | 0.5135 | 1.83 | 3,475,601 | -1.04 | -47.06% |
| 3 Years | 2.21 | 4.285 | 0.5135 | 1.83 | 3,475,601 | -1.04 | -47.06% |
| 5 Years | 2.21 | 4.285 | 0.5135 | 1.83 | 3,475,601 | -1.04 | -47.06% |
Psyence Biomedical Description
| Psyence cultivates natural psilocybin mushrooms (Psilocybe Cubensis) at our federally licensed ISO22000 facility in Southern Africa. This product is produced for export to our partners across the world to beprocessed into a standardised encapsulated product. |
